The global CAR T-cell therapy market is projected to reach approximately USD 19.5 billion by 2033, up from USD 3.3 billion in 2023, reflecting a compound annual growth rate (CAGR) of 18.2% over the forecast period from 2023 to 2033.
Chimeric Antigen Receptor T-cell (CAR T-cell) therapy is a groundbreaking advancement in the field of immunotherapy, offering new hope for patients with...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian